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focus in this area, with two main approaches. (1) Alkyne deactivation: Protected alkynes allow orthogonal control (Scheme 1a). 8 While this has led to a number of elegant reports of sequential click reactions, the order of reactivity is typically determined at inception with little opportunity for diversification. (2) Alkyne activation: several highly reactive alkynes have been developed to establish a reactivity gradient. 9 However, truly orthogonal reactivity has only been demonstrated in strainpromoted alkyne-azide cycloaddition (SPAAC)/CuAAC bifunctional systems where the high azidophilicity of cyclic alkynes allows selectivity over terminal alkynes in the absence of a Cu catalyst (Scheme 1b). 10 Transient protection of cyclooctynes offers sequential control; 11 however, the formation of regioisomeric products from SPAAC can pose problems for downstream applications due to potential differences in regioisomer pharmacology. 12 At present, sequential CuAAC methodologies are uni-directional, i.e., there is a pre-designed deactivation of one alkyne and this reactivity gradient cannot be completely overturned. In addition, few methods are available to perform sequential CuAAC reactions exploiting chemoselective control of both alkyne and azide reagents. 13 Here we describe a conditional strategy for complete orthogonal control over CuAAC reactions in multi-alkyne/azide systems using a single aromatic ynamine construct (Scheme 1c). Orthogonal alkyne/ynamine selectivity using a conditional strategy.
Aromatic ynamines display enhanced reactivity over a series of more conventional alkynes due to a shift in the rate-determining step (RDS) of this class of reagent. 14 The enhanced reactivity of an ynamine, (e.g., 1) vs. a standard terminal alkyne (e.g., 2a) enables chemoselective triazole formation under CuAAC conditions (Scheme 2).
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Scheme 2. Design plan.
The reciprocal reaction, i.e., chemoselective reaction at the less reactive alkyne, is rather more difficult based on this kinetic profile. This is another example of uni-directional CuAAC. However, we reasoned that conditional orthogonal control could be delivered using a simple protecting group strategy. Specifically, TIPS protection of 1 to give 4 would block the natural reactivity of 1 and thereby allow the reaction of a less reactive alkyne (e.g., 2a). This would effectively reverse the reactivity trend. To restore the normal reactivity, a rapid in situ silyl deprotection using a fluoride source would deliver 1 that would then react preferentially (Scheme 2). This approach would deliver a conditional bi-directional strategy for sequential control of two CuAAC reactions.
We began our investigation through the reaction of 4, benzyl azide (BnN 3 , 6a), and a representative terminal alkyne (2a) under a range of standard reaction conditions (Table 1) and TBAF or polymer-supported fluoride were unsuccessful in any solvent mixture, delivering mixtures of products (entries 2-6). Removal of Cu-ligating additives and variation of the solvent (entries 7-10) led quickly to a system that delivered complete chemoselectivity for 3a (entry 10).
Solvent choice was an important factor for chemoselective control. Standard CuAAC solvent mixtures of DMSO/H 2 O conditions operated well for CuAAC reaction of the alkyl alkyne 2a whereas DMSO and DMSO/H 2 O mixtures were not effective for selectivity at the ynamine 4. Ynamine selectivity was optimum using MeCN as the reaction medium. This difference in medium may be attributable to the requirement for sodium ascorbate (NaAsc) as an additive to promote reaction of 2a and the improved solubility of NaAsc in H 2 O. NaAsc was not necessary for reaction of 4. That 4 does not need NaAsc as a promoter may be attributable to reduction of Cu(II) to Cu(I) via Glaser coupling. 2 Since complete chemoselectivity for reaction at the ynamine using the in situ deprotection method (entry10), this suggests that the silyl deprotection is sufficiently rapid to have little consequence of the CuAAC process, i.e., the overall rate of silyl deprotection and CuAAC of 4 is less than the CuAAC rate of 2a. With optimized conditions for orthogonal reactivity in this benchmark system established, we progressed to look at the generality of the process. The scope and orthogonality of the developed conditions A (ynamine-selective) and B (alkyne-selective) was first assessed using a series of azide components (Scheme 3). Both sets of conditions proved to be robust, selectively delivering the expected products in high yield regardless of steric or electronic nature of the azide. In addition biorelevant azides were well tolerated, such as the fluorophores 6g-i, and biotinyl azide 6j. Lastly, we investigated the ability to simultaneously control both chemoselectivity at the alkyne as well as the azide component through exploitation of chelate-assistance to afford control over the azide (Scheme 6).
7 Under alkyne-selective conditions (Conditions A), the multicomponent reaction of 2e, 4, 6a, and 6f delivers product pair 3a and 12 via first CuAAC reaction of 2e with the more reactive azide 6f. 7a Addition of TBAF liberates the reactive ynamine allowing the second CuAAC reaction with azide 6a to take place. Alternatively, the orthogonal product pair, 3f and 7e, is generated using the ynamine-selective protocol (Conditions B) to promote the reaction of ynamine with 6f and the alkyne with 6a.
Scheme 6. Reactivity pairing of sequential CuAAC reactions. Isolated yields. series HPLC using a Machery-Nagel Nucleodur C18 column. Analysis was performed using a gradient method, eluting with 5 Ð 80% MeCN/H 2 O over 50 minutes at a flow rate of 1 mL/min.
CONCLUSIONS
Samples for HPLC analysis were prepared through the removal of 30 µL of the reaction mixture in which 100 µL of EDTA solution (10 mg/mL) was added. The product was extracted with 100 µL of DCM. The organics were concentrated, and the product was dissolved in MeOH (1 mL). To 110 µL of this solution was added 5 µL of 2-bromopyrimidine solution (10 mg/mL in MeOH) for HPLC analysis. Note: Due to the high heteroatom count in specific products, 13 
C NMR analysis was not possible due to issues with relaxation.
General Procedures. General Procedure A for the formation of 3a-j (Scheme 3). To a solution of 5,6-
imidazole (45 mg, 0.14 mmol, 1 equiv), (but-3-yn-1-yloxy)benzene (20 mg, 0.14 mmol, 1 equiv) and azide 6a-j (0.14 mmol, 1 equiv) at rt in MeCN (1 mL) was added TBAF (49 µL, 0.15 mmol, 1.1 equiv) followed by Cu(OAc) 2 (1 mg, 0.007 mmol, 0.05 equiv). The reaction was stirred for 16 h, after which EtOAc (10 mL) was added. The mixture was washed with EDTA (10 mg/mL, 10 mL) and brine (2 x 10 mL), dried over Na 2 SO 4 , and concentrated under vacuum. The resulting residue was purified by flash chromatography (silica gel) to provide the desired compound.
General Procedure B for the formation of 5a-j (Scheme 3). To a solution of 5,6-dimethyl-1-
imidazole (45 mg, 0.14 mmol, 1 equiv), (but-3-yn-1-yloxy)benzene (20 mg, 0.14 mmol, 1 equiv) and azide 5a-j (0.14 mmol, 1 equiv) at rt in DMSO/H 2 O
(1/1, 1 mL) was added AMTC (3 mg, 0.014 mmol, 0.1 equiv) followed by Cu(OAc) 2 (1 mg, 0.007 mmol, 0.05 equiv) and NaAsc (3 mg, 0.014 mmol, 0.1 equiv). The reaction was stirred for 16 h, after which EtOAc (10 mL) was added. The mixture was washed with EDTA (10 mg/mL, 10 mL) and brine (2 x 10 mL), dried over Na 2 SO 4 , and concentrated under vacuum. The resulting residue was purified by flash chromatography (silica gel) to provide the desired compound.
General Procedure C for the formation of 7a-f (Scheme 4). To a solution of 5,6-dimethyl-1- and NaAsc (9 mg, 0.041 mmol, 0.1 equiv). The reaction was stirred for 16 h, after which EtOAc was added. The mixture was washed with EDTA (10 mg/mL, 10 mL) and brine (2 x 10 mL), dried over Na 2 SO 4 , and concentrated under vacuum. The resulting residue was purified by flash chromatography (silica gel) to provide the desired compound. 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-5,6-dimethyl-1H-benzo[d]imidazole (3a

N-(2-(4-(5,6-Dimethyl-1H-benzo[d]imidazol-1-yl)-1H-1,2,3-triazol-1-yl)ethyl)-N-methyl-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (3g
1-(3',6'-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-yl)-3-(3-(4-(5,6-dimethyl-1H-benzo[d]imidazol-1-yl)-1H-1,2,3-triazol-1-yl)propyl)thiourea (3i). Prepared using General Procedure
A. Red solid (66 mg, 85%). Purification on silica gel using DCM/MeOH 9/1). 1 13 C NMR could not be obtained due to relaxation issues. 
N-(2-(2-(2-(2-(4-(5,6-Dimethyl-1H-benzo[d]imidazol-1-yl)-1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide (3j
1-Benzyl-4-(2-phenoxyethyl)-1H-1,2,3-triazole (5a
1-Octyl-4-(2-phenoxyethyl)-1H-1,2,3-triazole (5b
1-((3s,5s,7s)-Adamantan-1-yl)-4-(2-phenoxyethyl)-1H-1,2,3-triazole (5c). Prepared using General
Procedure B. White solid (81 mg, quant). Purification on silica gel using hexane/EtOAc 3/7. 1 
(S)-4-(2-Phenoxyethyl)-1-(1-phenylethyl)-1H-1,2,3-triazole (5d). Prepared using General Procedure B.
White solid (67 mg, 84%). Purification on silica gel using hexane/EtOAc 3/7 
(S)-2-((tert-Butoxycarbonyl)amino)-6-(4-(2-phenoxyethyl)-1H-1,2,3-triazol-1-yl)hexanoic acid (5e).
Prepared using General Procedure B. White solid (46 mg, 82%). Purification on silica gel using DCM/MeOH 9/1, 0.1% AcOH. 1 13 C NMR could not be obtained due to relaxation issues.
2-((4-(2-Phenoxyethyl)-1H-1,2,3-triazol-1-yl)methyl)pyridine (5f
N-Methyl-7-nitro-N-(2-(4-(2-phenoxyethyl)-1H-1,2,3-triazol-1-yl)ethyl)benzo[c][1,2,5]oxadiazol-4-amine (5g). Prepared using General
5-(Dimethylamino)-N-(3-(4-(2-phenoxyethyl)-1H-1,2,3-triazol-1-yl)propyl)naphthalene-1-sulfonamide (5h). Prepared using General
1-(3',6'-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-yl)-3-(3-(4-(2-phenoxyethyl)-1H-1,2,3-triazol-1-yl)propyl)thiourea (5i
5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(2-(2-(2-(2-(4-(2-phenoxyethyl)-
1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)ethyl)pentanamide (5j). Prepared using General Procedure
B. White solid (32 mg, 88%). Purification on silica gel using DCM/MeOH 9/1. 2 (1 mg, 0.006 mmol, 0.05 equiv.). The reaction was stirred at rt for 16 h, after which DCM (10 mL) was added. The mixture was washed with aq. EDTA (10 mg/mL, 10 mL), brine (2 x 10 mL), dried over Na 2 SO 4 , and concentrated under reduced pressure.
5-(1-Benzyl-1H-1,2,3-triazol-4-yl)-N-(1-((triisopropylsilyl)ethynyl)-1H-benzo[d]imidazol-6-yl)pentanamide (9a). To a solution of N-(1-((triisopropylsilyl)ethynyl)-1H-benzo[d]imidazol-6-
The resulting residue was purified by flash chromatography (silica gel, 7/3 EtOAc/hexane) to provide the desired product as a white solid (45 mg, 96% 
N-(1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1H-benzo[d]imidazol-6-yl)hept-6-ynamide (10b). To a solution of N-(1-((triisopropylsilyl)ethynyl)-1H-benzo[d]
imidazol-6-yl)hept-6-ynamide (50 mg, 0.12 mmol, 1 equiv.) in MeCN (1 mL) was added benzyl azide (15 µL, 0.119 mmol, 1 equiv.), TBAF (43 µL, 0.13 mmol, 1.1 equiv.), and Cu(OAc) 2 (1 mg, 0.006 mmol, 0.05 equiv.). The reaction was stirred at rt for 2 h, after which DCM (10 mL) was added. The mixture was washed with aq. EDTA (10 mg/mL, 10 mL), brine (2 x 10 mL), dried over Na 2 SO 4 , and concentrated under reduced pressure. The resulting residue was purified by flash chromatography (silica gel, 9/1 EtOAc/hexane) to provide the desired product as a white solid (47 mg, 98% ). The reaction was stirred at rt for 16 h, after which DCM (10 mL) was added. The mixture was washed with aq. EDTA (10 mg/mL, 10 mL), brine (2 x 10 mL), dried over Na 2 SO 4 and concentrated under reduced pressure. The resulting residue was purified by flash chromatography (silica gel, 9/1 EtOAc/hexane) to provide the desired product as a white solid (25 mg, 94%). Cu cat.
5-(1-Benzyl-1H-1,2,3-triazol-4-yl)-N-(1-(1-cyclohexyl-1H-1,2,3-triazol-4-yl)-1H-benzo[d]imidazol-6-yl)pentanamide (11a). Method
